Shanghai Sanyou Medical Co. Ltd. Class A

As of June 30, 2026, Shanghai Sanyou Medical Co. Ltd. Class A carries a market capitalization of 4.39B, placing it among publicly traded companies globally. Its enterprise value stands at 3.90B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Shanghai Sanyou Medical Co. Ltd. Class A's next confirmed earnings release is scheduled for October 27, 2026.

As of June 30, 2026, Shanghai Sanyou Medical Co. Ltd. Class A has 366.81M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Shanghai Sanyou Medical Co. Ltd. Class A maintains a current ratio of 5.53, meaning it holds 5.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Shanghai Sanyou Medical Co. Ltd. Class A recorded 737,280.09 in income tax expense.

As of the close on October 23, 2026, Shanghai Sanyou Medical Co. Ltd. Class A's stock has declined approximately 27.07% over the past 52 weeks. The 50-day moving average sits at 13.08, while the 200-day moving average is 15.25.

As of June 30, 2026, Shanghai Sanyou Medical Co. Ltd. Class A holds 539.81M in cash and equivalents against 35.04M in total debt, resulting in a net debt position of -329.07M. Total book value stands at 2.14B, with working capital of 965.32M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Shanghai Sanyou Medical Co. Ltd. Class A paid dividends of 0.02 per share.

Shanghai Sanyou Medical Co. Ltd. Class A's most recent stock split took place on June 11, 2026 with a 10:11 split ratio.